?????? ?? ???? ??? ??? ????? ?? ? ?? ?? ??? ?????. ????? ?? ???? ??? ? ?? ?? ???? ?? ? ???, 30??? 1?? ??? ??? ????. ?? ? ?? 1? ??? ??? ??? ???? ???. ???? ?? ?? ??? ?? ?? ???? ??? ??? ?????. ?? ????? ?????? ??? ??? ????? ??? ????? ??? ?? ?????. ??? ???? ?? ?? ???? ????. ?? ? ??? ? ?? ????

In October 2007, the FDA introduced the labeling for all PDE5 inhibitors, like tadalafil, requires a more prominent warning of the opportunity chance of sudden Listening to reduction as the result of post-advertising studies of short term deafness linked to usage of PDE5 inhibitors.[19] Although